Kristofer Svensson
Direttore Finanziario/CFO presso GABATHER AB
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Rajni Hatti-Kaul | M | 65 | 10 anni | |
Christer Edlund | M | - | 11 anni | |
Michael Robin Witt | M | - | 10 anni | |
Mohammad Ibrahim | M | 47 | 10 anni | |
Marie-Lois Ivarsson | M | - | 11 anni | |
Claes Håkan Björnberg | M | 65 | 5 anni | |
Leif Robert Nilsson | M | 72 | 5 anni | |
Carl Edvard Georg Hall | M | 39 | 6 anni | |
Fredrik Andersson | M | - | 4 anni | |
Christine Natasha Ryan | M | - | - | |
Johan Sandin | M | 54 |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | - |
Robert Per Hökfelt | M | 58 | 5 anni | |
Bert Roland Kari Junno | M | 58 | 10 anni | |
Stefan Rehnmark | M | - | - | |
Christoph Nowak | M | 38 |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | - |
Anders Lönnberg | M | - | 3 anni | |
Sjödin Fredrik | M | 50 | 3 anni | |
Philip Slatis | M | - | 2 anni | |
Austin Smith | M | - | 2 anni | |
Lars Christer Fedrik Fåhraeus | M | 59 |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | - |
Bror Thomas Pollare | M | 71 |
Sinfonia Biotherapeutics AB
Sinfonia Biotherapeutics AB BiotechnologyHealth Technology Sinfonia Biotherapeutics AB is a clinical stage company based in Huddinge, Sweden. The Swedish company develops biologics for the treatment of neuropathic pain. | - |
Mats Persson | M | 61 | 2 anni | |
Hans-Peter Albert Ostler | M | 53 | 2 anni | |
Anna Sjöblom-Hallén | M | - | 8 anni | |
Theresa Comiskey Olsen | F | 61 |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Melius Pharma AB is a Swedish clinical stage pharmaceutical company that develops new treatments for chronic cough in idiopathic pulmonary fibrosis (IPF) patients. The company is based in Lund, Sweden and is privately owned, benefiting from the support of two of Sweden's most prominent professional life science investors who bring expertise to develop the company. IPF is a chronic, progressive lung inflammation characterized by fibrosis and disruption of normal lung architecture. Melius Pharma has developed ME-015, which stabilizes ion channels in the neuronal endings in the lungs that mediate cough. ME-015 is presumed to have an acute effect and is a solution for chronic cough, which is one of the major symptoms experienced by 80%% of IPF patients. | - |
Göran Gannedahl | M | 71 | 2 anni | |
Klas Ingstorp | M | 53 | 2 anni | |
Kevan Cassidy | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Bengt Håkan Englund | M | 72 | 7 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Svezia | 29 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Kristofer Svensson
- Contatti personali